Skip to main content
Log in

Inhibitory effect of curcumin onWT1 gene expression in patient leukemic cells

  • Articles
  • Drug Development
  • Published:
Archives of Pharmacal Research Aims and scope Submit manuscript

Abstract

Leukemias are common worldwide. Wilms'tumor1 (WT1) protein is highly expressed in leukemic blast cells of myeloid and lymphoid origin. Thus, WT1 mRNA serves as a tumor marker for leukemias detection and monitoring disease progression. Curcumin is well known for its anticancer property. The objective of this study was to investigate the effect of curcumin onWT1 gene expression in patient leukemic cells. The leukemic cells were collected from 70 childhood leukemia patients admitted at Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand, in the period July 2003 to February 2005. There were 58 cases of acute lymphoblastic leukemia (ALL), 10 cases of acute myeloblastic leukemia (AML), and 2 cases of chronic myelocytic leukemia (CML). There were 41 males and 29 females ranging from 1 to 15 years old. Leukemic cells were cultured in the presence or absence of 10 mM curcumin for 48 h. WT1 mRNA levels were determined by RT-PCR. The result showed that curcumin reducedWT1 gene expression in the cells from 35 patients (50%). It affected theWT1 gene expression in 4 of 8 relapsed cases (50%), 12 of 24 cases of drug maintenance (50%), 7 of 16 cases of complted treatment (44%), and 12 of 22 cases of new patients (54%). The basal expression leveles ofWT1 gene in leukemic patient cells as compared to that of K562 cells were classified as low level (1–20%) in 6 of 20 cases (30%), medium level (21–60%) in 12 of 21 cases (57%), and high level (61–100%) in 17 of 23 cases (74%). In summary, curcumin decreased WT1 mRNA in patient leukemic cells. Thus, curcumin treatment may provide a lead for clinical treatment in leukemic patients in the future.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Alley, M. C. and Scudiero, D. A., Monks, A. Feasibility of drug screening with panels of human tumour cell lines using a microculture tetrazolium assay.Cancer Res., 48, 589–601 (1988).

    PubMed  CAS  Google Scholar 

  • Ammon, H. P. T. and Wahl, M. A., Pharmacology ofCurcuma longa.Planta Med., 57, 1–7 (1991).

    Article  PubMed  CAS  Google Scholar 

  • Anuchapreeda, S., Leechanachai, P., Smith, M., Ambudkar, S. V., and Limtrakul, P., Modulation of P-glycoprotein expression and function by curcumin in Multidrug resistant human KB cells.Biochem. Pharmacol., 64, 573–582 (2002).

    Article  PubMed  CAS  Google Scholar 

  • Bergmann, L., Miething, C., Maurer, U., Brieger, J., Karakas, T., Weidmann, E., and Hoelzer, D., High level of Wilms' tumor gene (WT) mRNA in acute myeloid leukemia are associated with a worse long-term outcome.Blood, 90, 1217–1225 (1997).

    PubMed  CAS  Google Scholar 

  • Dovoix, A., Morcean, F., Delhalle, S., Schmitz, M., Schnekenburger, M., Galteau, M. M., Dicota, M., and Diederich, M., Inhibition of apoptosis by curcumin mediation by glutathione S-transferase P1-1 inhibition.Biochem. Pharmacol., 66, 1475–1483 (2003).

    Article  CAS  Google Scholar 

  • Fraizer, G. C., Patmasiriwat, P., Zhang, X. H., and Saunders, G. F., Expression of the tumour suppressor gene WT1 in both human and bone marrow.Blood, 86, 4704–4706 (1995).

    PubMed  CAS  Google Scholar 

  • Govindarajan, V. S., Tumeric: Chemistry, technology and quality.CRC Crit. Rev. Food Sci. Nutr., 12, 199–301 (1990).

    Article  Google Scholar 

  • Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T., Nasu, K., Kyo, T., Dohy, H., Nakauchi, H., Ishidate, T., Akiyama, T., and Kishimoto, T., WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia.Blood, 84, 3071–3079 (1994).

    PubMed  CAS  Google Scholar 

  • Kunchandy, E. and Rao, M. N. A., Oxygen radical scarvenging activity of curcumin.Int. J. Pharm., 58, 237–240 (1990).

    Article  CAS  Google Scholar 

  • Kuo, M. L., Huang, T. S., and Lin, J. K., Curcumin, an antioxidant and antitumor promoter, induces apoptosis in human leukemia cells.Biochim. Biophys. Acta, 1317, 95–100 (1996).

    PubMed  CAS  Google Scholar 

  • Limtrakul, P., Anuchapreeda, S., Lipogorngoson, S., and Dunn, F. W., Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin.BMC Cancer, 1, 1–7 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Limtrakul, P., Chearwae, W., and Anuchapreeda, S., The effect of curcumin on the proliferation of cancer cell lines.Chiang Mai Med. Bull., 38, 55–61 (1999).

    Google Scholar 

  • Limtrakul, P., Lipigorngoson, S., Namwong, O., Apisariyakul, A., and Dunn, F. W., Inhibitory effect of dietary curcumin on skin carcinogenesis in mice.Cancer Lett., 116, 197–203 (1997).

    Article  PubMed  CAS  Google Scholar 

  • Lorvidhaya, V. and Srisukho, S., Annual report 1999; Chiang Mai Cancer registry, Academic-Publishing Unit, Faculty of Medicine, Chiang Mai University: Chiang Mai., 23, 51 (2002).

    Google Scholar 

  • Miwa, H., Beran, M., and Saunders, G. F., Expression of Wilms' tumor gene in human leukemias.Leukemia, 6, 405–409 (1992).

    PubMed  CAS  Google Scholar 

  • Miyaki, T., Ahuji, H., Kubota, T., Kubonishi, I., Koeffler, H. P., and Miyoshi, I., Expression of candidate Wilms' tumor gene, WT1, in human leukemia cells.Leukemia, 7, 970–977 (1993).

    Google Scholar 

  • Nagabhushan, M., Amonkar, A. J., and Bhide, S. V.,In vitro antimutagenicity of curcumin against environmental mutagens.Food Chem. Toxicol., 25, 545–547 (1987).

    Article  PubMed  CAS  Google Scholar 

  • Oji, Y., Ogawa, H., Tamaki, H., Oka, Y., Tsuboi, A., Kim, E. H., Soma, T., Tatekawa, T., Kawamaki, M., Asada, M., Kishimoto, T., and Sugiyama, H., Expression of Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth.Jpn. J. Cancer Res., 90, 194–204 (1999).

    PubMed  CAS  Google Scholar 

  • Patmasiriwat, P., Fraizer, G. C., Claxton, D., Kantarjian, H., and Saunders, G. F., Expression of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities.Leukemia, 10, 1127–1133 (1996).

    PubMed  CAS  Google Scholar 

  • Phelan, S. A., Lindberg, C., and Call, K. M., Wilms' tumor gene, WT1, mRNA is down-regulated during induction of erythroid and megakaryocytic differentiation of K562 cells.Cell Growth Differ., 5, 677–686 (1994).

    PubMed  CAS  Google Scholar 

  • Qureshi, S., Shah, A. H., and Ageel, A. M., Toxicity studies onAlpinia galanga andCurcuma longa, Planta Med., 58,124–127 (1992).

    Article  PubMed  CAS  Google Scholar 

  • Rao, C. V., Rivenson, A., Simi, B., and Reddy, B. S., Chemoprevention of colon cancer by dietary curcumin.Ann. NY Acad. Sci., 768, 201–204 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Rao, D. S., Sekhara, N. C., Satyanarayana, M. N., and Srinivasan, M., Effect of curcumin on serum and liver cholesterol levels in the rat.J. Nutr., 100, 1307–1315 (1970).

    PubMed  CAS  Google Scholar 

  • Sekiya, M., Adachi, M., Hinoda, Y., Imai, K., and Yachi, A., Down-regulation of Wilms' tumor gene (WT1) during myelomonocytic differentiation in HL60 cells.Blood, 83, 1876–1882 (1994).

    PubMed  CAS  Google Scholar 

  • Shankar, T. N., Shantha, N. V., Ramesh, H. P., Murthy, I. A., and Murthy, V. S., Toxicity studies on Turmeric: acute toxicity studies in rats, guinea pigs and monkeys.Indian. J. Exp. Biol., 18, 73–75 (1980).

    PubMed  CAS  Google Scholar 

  • Soudamini, K. K. and Kuttan, R., Inhibition chemical carcinogenesis by curcumin.J. Ethnopharmacol., 27,227–233 (1989).

    Article  PubMed  CAS  Google Scholar 

  • Srinivasan, M., Effect of curcumin on blood sugar as seen in a diabetic subject.Indian J. Med. Sci., 26, 269–270 (1972).

    PubMed  CAS  Google Scholar 

  • Sriplung, H., Sontipong, S., Martin, N., Wiangnon, S., Vootipong, V., Cheirsilpa, A., Kanchanabat, C., and Khuhaprema, T., Cancer in Thailand, Bangkok; Medical Publisher: Bangkok, 3, Chapter II, 66–69 (2003).

    Google Scholar 

  • Sugiyama, H., Wilms' tumor gene WT1: Oncogenic function and clinical application.Int. J. Hematol., 73, 177–187 (2001).

    Article  PubMed  CAS  Google Scholar 

  • Tamaki, H., Ogawa, H., Inoue, K., Soma, T., Yamagami, T., Miyake, S., Oka, Y., Oji, Y., Tatekawa, T., Tsuboi, A., Tagawa, S., Kitani, T., Miwa, H., Kita, K., Aozasa,K., Kishimoto, T., and Sugiyama, H., Increased expression of the Wilms' tumor gene (WT1) at relapse in acute leukemia.Blood, 88, 4396–4398 (1996).

    PubMed  CAS  Google Scholar 

  • Wu, Y. J., Fraizer, D. C., and Suanders, G. F., GATA-1 transactivates the WT1 hematopoietic specific enhancer.J. Biol. Chem., 270, 5944–5949 (1995).

    Article  PubMed  CAS  Google Scholar 

  • Yamagami, T., Sugiyama, H., Inoue, K., Ogawa, H., Tatekawa, T., Hirata, M., Kudoh, T., Akiyama, T., Murakami, A., Maekawa, T., and Kishimoto, T., Growth inhibition of human leukemic cells by WT1 (Wilms' tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis.Blood, 87, 2878–2884 (1996).

    PubMed  CAS  Google Scholar 

  • Ye, Y., Raychaudruri, B., Gurney, A., Campbell, C. E., and Williams, B. R., Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptionalactivity and cellular translation.EMBO J., 15, 5606–5615 (1996).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Songyot Anuchapreeda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anuchapreeda, S., Limtrakul, P., Thanarattanakorn, P. et al. Inhibitory effect of curcumin onWT1 gene expression in patient leukemic cells. Arch Pharm Res 29, 80–87 (2006). https://doi.org/10.1007/BF02977473

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02977473

Key words

Navigation